The Shotlee Journal
Browse Shotlee articles about Health & Wellness.
Showing 9 / 258 Health & Wellness articles
Discover the fascinating connection between your gut microbiome, the food you eat, and the natural hormones that regulate appetite and metabolism. Learn how these internal systems are similar to groundbreaking weight loss medications like Ozempic, Wegovy, and Mounjaro.
Social media trends and GLP-1 medications are reshaping how Utah students view health. Explore the balance between medical weight management and sustainable habits.
The rise of GLP-1 medications is no longer a whisper; it's a culinary revolution. From shrinking appetites to evolving tastes, these powerful drugs are prompting a significant shift in how we eat out, forcing restaurants to adapt their offerings and dining strategies.
Many users of GLP-1 medications like Ozempic and Wegovy report experiencing 'Ozempic personality,' a phenomenon characterized by emotional flattening and a reduced interest in formerly enjoyable activities. This article delves into what this means, potential causes, and how to navigate these changes.
A groundbreaking discovery using artificial intelligence has identified a naturally occurring molecule, BRP, that targets the brain's appetite center, potentially offering a new and improved alternative for weight management compared to current GLP-1 medications.
The world of biohacking is increasingly embracing peptides, but what's the reality behind the hype? This article delves into the science, the risks of unregulated substances, and the potential impact of regulatory changes on access to these compounds.
While GLP-1 medications like Ozempic and Mounjaro offer significant weight loss potential, many individuals experience plateaus. Discover how a simple, affordable supplement – psyllium husk – can amplify their effects, improve satiety, and support long-term weight management.
As brand-name GLP-1 medications such as Ozempic and Wegovy become increasingly sought after for weight loss and diabetes management, many Canadians face significant cost barriers. The anticipation surrounding the approval of generic semaglutide offers a beacon of hope for improved accessibility and affordability. This article delves into the current landscape, patient stories, and expert insights on the journey towards more accessible peptide therapies.
Kaitlin Hicks, a former athlete, shares her powerful story of overcoming grief-induced weight gain, her health struggles, and her triumphant return to sport after losing a significant amount of weight.
